BridgeBio Pharma Gross Profit Growth & History (BBIO)
BridgeBio Pharma's gross profit was $481.1M for fiscal 2025.
View full BridgeBio Pharma company overviewBridgeBio Pharma annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $481.1M | $263.1M | +120.67% |
| 2024 | 2024-12-31 | $218.0M | $211.2M | +3079.58% |
| 2023 | 2023-12-31 | $6.9M | −$67.4M | −90.76% |
| 2022 | 2022-12-31 | $74.2M | $7.6M | +11.43% |
| 2021 | 2021-12-31 | $66.6M | — | — |
BridgeBio Pharma quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $228.6M | $121.7M | +113.85% |
| Q1 2026 | 2026-03-31 | $184.6M | $70.6M | +61.92% |
| Q4 2025 | 2025-12-31 | $146.1M | $142.3M | +3746.00% |
| Q3 2025 | 2025-09-30 | $114.1M | $112.0M | +5248.50% |
| Q2 2025 | 2025-06-30 | $106.9M | $105.3M | +6709.68% |
| Q1 2025 | 2025-03-31 | $114.0M | −$96.5M | −45.85% |
| Q4 2024 | 2024-12-31 | $3.8M | $2.7M | +231.12% |
| Q3 2024 | 2024-09-30 | $2.1M | −$1.4M | −38.91% |
| Q2 2024 | 2024-06-30 | $1.6M | $528,000 | +50.67% |
| Q1 2024 | 2024-03-31 | $210.5M | $209.3M | +17816.77% |
| Q4 2023 | 2023-12-31 | $1.1M | — | — |
| Q3 2023 | 2023-09-30 | $3.5M | $3.9M | — |
| Q2 2023 | 2023-06-30 | $1.0M | −$72.0M | −98.57% |
| Q1 2023 | 2023-03-31 | $1.2M | — | — |
| Q3 2022 | 2022-09-30 | −$401,000 | −$1.3M | — |
| Q2 2022 | 2022-06-30 | $73.0M | $19.1M | +35.48% |
| Q3 2021 | 2021-09-30 | $890,000 | −$7.2M | −89.05% |
| Q2 2021 | 2021-06-30 | $53.9M | — | — |
| Q3 2020 | 2020-09-30 | $8.1M | — | — |
BridgeBio Pharma gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, BridgeBio Pharma's gross profit increased from $66.6M to $481.1M, a change of $414.5M. The latest reported quarter, Q2 2026, shows $228.6M.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BridgeBio Pharma source filings ↗